Concepedia

Aaron Goldman

AG

33

Publications

1.7K

Citations

23

H-Index

2006

Active since

Affiliations

Harvard University(Current)

Brigham and Women's Hospital

University of Waterloo

University of Arizona

Dana-Farber Cancer Institute

Aaron Goldman is an author at Harvard University specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2006–2023

33

Publications

33

Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition

Aaron Goldman, Biswanath Majumder, Andrew Dhawan et al. · Nature Communications · 2015 · 284 citations · Full text

Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype

Marcelo Boareto, Mohit Kumar Jolly, Aaron Goldman et al. · Journal of The Royal Society Interface · 2016 · 145 citations · Full text

NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells

Wucheng Qi, Kishore Shakalya, A Stejskal et al. · Oncogene · 2008 · 118 citations

, , +8

Role of cyclophilin D in the resistance of brain mitochondria to the permeability transition

Roman A. Eliseev, Gleb Filippov, Janice Velos et al. · Neurobiology of Aging · 2006 · 76 citations

, , +13

Reporter nanoparticle that monitors its anticancer efficacy in real time

Ashish Kulkarni, Poornima Rao, Siva Kumar Natarajan et al. · Proceedings of the National Academy of Sciences · 2016 · 76 citations · Full text

Rows per page

1–5 of 33